PeakLogic

What PeakLogic does

PeakLogic, Inc. is a privately held, San Diego-headquartered healthcare technology company that developed and licenses PrTMS, a patented protocol for Personalized repetitive Transcranial Magnetic Stimulation (rTMS). The company's core technology combines quantitative electroencephalogram (qEEG) brainwave analysis with neurocognitive evaluations to generate individualized rTMS treatment plans, which are then verified and approved by certified PrTMS providers; treatment parameters are dynamically monitored and adjusted through weekly EEG tracking. PrTMS is positioned as targeting the underlying neurological source (described by the company as "brain arrhythmia") of a broad range of conditions including depression, anxiety, PTSD, OCD, sleep disorders, migraine, addiction, ADD/ADHD, autism spectrum disorder, and concussion, with stated extensions into human performance optimization for athletes, executives, and special operations personnel.

PeakLogic operates a B2B2C licensing and managed-services model rather than delivering treatment directly. The company recruits, trains, and certifies independent healthcare practices and clinics to join its network; providers gain access to the proprietary protocol, a dedicated provider portal, and ongoing clinical support, and they in turn deliver PrTMS treatments to patients in their local markets. Multi-year contracts are used and pricing is not publicly disclosed, with commercial terms shaped by practice size, specialty, and patient demographics. The certified provider network spans 40+ locations across more than 20 US states plus international sites in India (Chennai) and Canada (British Columbia).

The company pursues clinical validation through collaborations with Walter Reed National Military Medical Center, the Henry M. Jackson Foundation, Massachusetts General Hospital (including its Home Base program), the Air Force Research Laboratory, and USSOCOM on trials covering chronic neck pain and PTSD in military service members, alongside peer-reviewed publications such as an August 2024 pilot study on autism in the Journal of Personalized Medicine. PeakLogic is a US veteran-founded organization, with Kevin T. Murphy, MD identified as founder and a co-author on multiple PrTMS research publications. The company holds registered trademarks for PrTMS, PeakLogic, the company logo, and "the peak," and maintains HIPAA, CCPA, and GDPR-aligned data practices. No institutional venture funding rounds or parent company have been disclosed in the source material.

Name

PeakLogic

Legal name

PeakLogic, Inc.

Website

https://prtms.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

PeakLogic is a privately held, San Diego-based healthcare technology company that licenses PrTMS, a patented, qEEG-guided personalized rTMS protocol, to a network of 40+ certified provider practices across the US, India, and Canada for treating mental health, neurological, and performance-related conditions.

Ownership category

akta.pro rank

Product category

Neuromodulation Therapy Services

NAICS

Professional, Scientific, and Technical Services (541)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)

akta.pro secondary industry

Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms (HLALABAK)

Keywords

• Transcranial magnetic stimulation
• Neuromodulation therapy
• Personalized brain treatment
• TMS provider network
• Brain arrhythmia treatment

Headquarters

HQ city

San Diego

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Others

Revenue model

1. Provider Licensing & Certification: PeakLogic licenses its proprietary PrTMS protocol to healthcare providers and clinics who wish to offer personalized TMS treatments. Providers receive access to treatment protocols, training, certification, and ongoing clinical support.
2. Treatment Delivery Support: The company supports the delivery of PrTMS treatments through its network of certified providers, with treatment plans providing recommendations for low amplitude, non-invasive magnetic energy pulses personalized to each patient.

Pricing tiers

Go-to-market motion3 records

Distribution channels1 record

Marketing channels6 records

Core offering

PeakLogic licenses and supports PrTMS® (Personalized repetitive Transcranial Magnetic Stimulation), a patented protocol that uses quantitative electroencephalogram (qEEG) brainwave analysis and neurocognitive evaluations to generate individualized rTMS treatment plans. The company recruits, trains, and certifies healthcare provider practices and clinics to deliver PrTMS therapy to patients suffering from treatment-resistant mental health and neurocognitive conditions.

Product overview

PeakLogic offers a single unified product: PrTMS® (Personalized repetitive Transcranial Magnetic Stimulation), a patented protocol for developing personalized rTMS treatment plans. The therapy uses an assessment of a patient's brainwaves and neurocognitive function to generate treatment plans tailored specifically to the individual, which are verified and approved by qualified PrTMS® providers. These customized treatment plans allow for a dynamic approach to neuromodulation. The company operates through a provider network model where healthcare practices deliver the PrTMS® therapy to patients.

Differentiator

Problem solved

Functional benefit

Brands

• PrTMS®: Personalized repetitive Transcranial Magnetic Stimulation (rTMS) treatment protocol developed by PeakLogic for treating various brain and mental health conditions.

Products and services

• PrTMS® (Personalized repetitive Transcranial Magnetic Stimulation) PrTMS® is a patented protocol that uses quantitative electroencephalogram (qEEG) brainwave analysis and neurocognitive function evaluations to generate personalized rTMS treatment plans, which are verified and approved by qualified PrTMS® providers. The protocol delivers low-amplitude, non-invasive magnetic energy pulses tailored to each patient and is intended for conditions including depression, anxiety, PTSD, OCD, sleep disorders, migraine, addiction, ADD/ADHD, autism, and concussion. It is licensed to and delivered through certified healthcare provider practices and clinics.

Quantifiable outcome

• PrTMS has shown positive therapeutic outcomes for concussion, autism spectrum disorder, PTSD in military combat veterans, and Major Depressive Disorder symptom severity reduction.

Named customers7 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core.

• Walter Reed National Military Medical CentercoreStrategic or Co-development PartnerActive clinical trial collaboration with Walter Reed National Military Medical Center and the Henry M. Jackson Foundation to assess PrTMS efficacy in reducing pain for military health system beneficiaries with chronic neck pain. Clinical trial registered at clinicaltrials.gov (NCT06214949).
• Henry M. Jackson Foundation for the Advancement of Military MedicinecoreStrategic or Co-development PartnerCo-development partner with Walter Reed National Military Medical Center on chronic neck pain clinical trial. Foundation supports military medical research initiatives.
• Massachusetts General HospitalcoreStrategic or Co-development PartnerActive collaboration with MGH, Home Base, and Air Force Research Laboratory in partnership with USSOCOM to assess PrTMS efficacy as treatment for PTSD in military service members and veterans. Clinical trial registered at clinicaltrials.gov (NCT07526285).
• Home Base (Massachusetts General Hospital)coreStrategic or Co-development PartnerCollaboration with Home Base (a Massachusetts General Hospital program) focused on PTSD treatment research for military veterans and service members.
• Air Force Research LaboratorycoreStrategic or Co-development PartnerPartner in PTSD treatment research collaboration with MGH, Home Base, and USSOCOM to evaluate PrTMS efficacy for military service members.
• United States Special Operations Command (USSOCOM)coreStrategic or Co-development PartnerStrategic partnership with USSOCOM for PTSD treatment research using PrTMS therapy, in collaboration with MGH, Home Base, and Air Force Research Laboratory.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• MagVenture: Danish TMS device manufacturer featured on PeakLogic's physician resources page. Although a current technology partner, MagVenture also sells its own treatment protocols to clinics, making it a partial competitor and channel risk for PeakLogic.
• Brainsway: Developer of Deep TMS systems with FDA clearance for MDD, OCD, and smoking cessation. Competes head-to-head with PeakLogic's PrTMS protocol because it offers its own proprietary coil-and-protocol combination sold directly to clinics.
• Neuronetics: Commercializes NeuroStar, the leading FDA-cleared TMS device for MDD and OCD. Direct competitor because it sells TMS equipment and bundled treatment protocols into the same psychiatric and neurology clinics that PeakLogic targets with PrTMS.
• Magstim: UK-based manufacturer of TMS stimulators and coils used widely in research and clinical practice. Direct competitor in the TMS device and protocol ecosystem, supplying hardware that competes with the MagVenture systems on which PrTMS currently runs.

Broad incumbents

• Spring Health: Enterprise mental health benefits platform offering therapy, medication management, and care navigation to employer plans. Comparable as a broad incumbent channel for mental health treatment delivery that increasingly bundles or partners with TMS providers like PeakLogic.
• Axsome Therapeutics: Commercial-stage CNS biopharma with FDA-approved therapies for major depressive disorder (Auvelity) and migraine. Adjacent incumbent competing for the same psychiatrist-prescriber mindshare and treatment-resistant depression patient population that PrTMS targets.

Emerging players

• Pear Therapeutics (legacy): Pioneer in prescription digital therapeutics for substance use disorder, insomnia, and other conditions before its 2023 bankruptcy. Relevant as a cautionary comparable for non-pharmaceutical, condition-specific therapeutic platforms that depend on reimbursement and provider adoption.
• Akili Interactive: Digital therapeutics company (FDA-cleared EndeavorRx for ADHD, developed EndeavorOTC for adults). Comparable as a non-pharmaceutical, software/technology-driven therapeutic option targeting attention and mental health conditions that overlap with PrTMS's ADHD and depression claims.
• Apollo Neuroscience: Sells a wearable low-frequency vibroacoustic stimulation device marketed for stress, sleep, and focus. Comparable as an emerging neuromodulation/wellness player targeting consumer performance and mental health use cases that overlap with PeakLogic's performance-optimization positioning.
• eNeura (now Terso Solutions): Maker of single-pulse TMS devices (SpringTMS/springTMS Total Migraine) for acute and preventive migraine treatment. Comparable as a smaller TMS player targeting a specific neurological indication (migraine) that overlaps with one of PrTMS's claimed indications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/peaklogic-prtms

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PeakLogic